Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 32 | 2025 | 242 | 10.990 |
Why?
|
| Central Nervous System | 12 | 2025 | 197 | 5.710 |
Why?
|
| Neuronal Plasticity | 9 | 2025 | 152 | 4.030 |
Why?
|
| Synapses | 10 | 2025 | 186 | 3.340 |
Why?
|
| Neurons | 14 | 2025 | 923 | 1.830 |
Why?
|
| Neurodegenerative Diseases | 5 | 2025 | 143 | 1.540 |
Why?
|
| Multiple Sclerosis | 8 | 2025 | 218 | 1.520 |
Why?
|
| Animals | 47 | 2025 | 20631 | 1.300 |
Why?
|
| Cytokines | 5 | 2023 | 934 | 1.250 |
Why?
|
| Neurogenesis | 3 | 2021 | 64 | 1.240 |
Why?
|
| Phagocytosis | 6 | 2024 | 264 | 1.220 |
Why?
|
| Astrocytes | 5 | 2025 | 119 | 1.210 |
Why?
|
| Neuroglia | 6 | 2024 | 79 | 1.050 |
Why?
|
| CX3C Chemokine Receptor 1 | 3 | 2025 | 13 | 1.040 |
Why?
|
| Rett Syndrome | 2 | 2016 | 8 | 0.990 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2016 | 15 | 0.980 |
Why?
|
| Macrophages | 8 | 2025 | 1038 | 0.940 |
Why?
|
| Brain | 10 | 2025 | 1555 | 0.920 |
Why?
|
| Wnt Signaling Pathway | 1 | 2025 | 81 | 0.910 |
Why?
|
| Mice | 26 | 2025 | 10827 | 0.910 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 3 | 2025 | 59 | 0.900 |
Why?
|
| Vibrissae | 2 | 2025 | 7 | 0.880 |
Why?
|
| Chemokine CX3CL1 | 2 | 2025 | 8 | 0.880 |
Why?
|
| Lipofuscin | 1 | 2023 | 5 | 0.860 |
Why?
|
| Phagocytes | 2 | 2014 | 52 | 0.860 |
Why?
|
| Nucleic Acids | 1 | 2024 | 60 | 0.840 |
Why?
|
| Integrases | 1 | 2023 | 37 | 0.820 |
Why?
|
| Interferon Regulatory Factors | 1 | 2022 | 43 | 0.770 |
Why?
|
| Seizures | 1 | 2022 | 143 | 0.710 |
Why?
|
| Synaptic Transmission | 2 | 2023 | 150 | 0.700 |
Why?
|
| Interleukin-6 | 2 | 2022 | 321 | 0.700 |
Why?
|
| Cerebral Cortex | 3 | 2020 | 260 | 0.700 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 175 | 0.680 |
Why?
|
| Complement C3 | 2 | 2019 | 59 | 0.660 |
Why?
|
| Immunity, Innate | 3 | 2024 | 796 | 0.660 |
Why?
|
| Cell Communication | 2 | 2025 | 130 | 0.650 |
Why?
|
| Ranvier's Nodes | 4 | 2011 | 4 | 0.640 |
Why?
|
| ADAM10 Protein | 1 | 2019 | 11 | 0.630 |
Why?
|
| Sensorimotor Cortex | 1 | 2019 | 4 | 0.630 |
Why?
|
| Mice, Inbred C57BL | 11 | 2025 | 3391 | 0.630 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 614 | 0.630 |
Why?
|
| Touch | 1 | 2019 | 27 | 0.620 |
Why?
|
| Thalamus | 1 | 2019 | 72 | 0.620 |
Why?
|
| Schizophrenia | 1 | 2021 | 265 | 0.610 |
Why?
|
| Axons | 3 | 2009 | 123 | 0.610 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2019 | 77 | 0.610 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 180 | 0.570 |
Why?
|
| Signal Transduction | 3 | 2025 | 3033 | 0.550 |
Why?
|
| Humans | 30 | 2025 | 63292 | 0.530 |
Why?
|
| Myelin Sheath | 3 | 2025 | 37 | 0.490 |
Why?
|
| Nervous System | 1 | 2016 | 70 | 0.490 |
Why?
|
| Organogenesis | 1 | 2015 | 39 | 0.470 |
Why?
|
| Macrophages, Peritoneal | 1 | 2015 | 77 | 0.460 |
Why?
|
| Membrane Proteins | 2 | 2025 | 894 | 0.450 |
Why?
|
| CpG Islands | 1 | 2015 | 216 | 0.430 |
Why?
|
| Immune System | 2 | 2015 | 130 | 0.420 |
Why?
|
| Oligodendroglia | 6 | 2025 | 36 | 0.410 |
Why?
|
| Macrophage-1 Antigen | 1 | 2012 | 30 | 0.380 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2009 | 86 | 0.370 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 388 | 0.370 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 147 | 0.360 |
Why?
|
| Cellular Senescence | 2 | 2025 | 110 | 0.360 |
Why?
|
| Cytoskeleton | 3 | 2020 | 138 | 0.360 |
Why?
|
| Microscopy, Confocal | 3 | 2023 | 235 | 0.340 |
Why?
|
| Mice, Knockout | 5 | 2025 | 2107 | 0.330 |
Why?
|
| Female | 13 | 2025 | 32787 | 0.330 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 2180 | 0.300 |
Why?
|
| Nerve Growth Factors | 2 | 2009 | 27 | 0.300 |
Why?
|
| Cell Adhesion Molecules | 2 | 2009 | 90 | 0.290 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2024 | 503 | 0.280 |
Why?
|
| Transcriptome | 5 | 2025 | 388 | 0.270 |
Why?
|
| Male | 13 | 2025 | 29814 | 0.270 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2006 | 30 | 0.260 |
Why?
|
| Cell Lineage | 2 | 2019 | 268 | 0.260 |
Why?
|
| Rats | 6 | 2019 | 1977 | 0.250 |
Why?
|
| Retinal Ganglion Cells | 2 | 2019 | 30 | 0.250 |
Why?
|
| Retina | 3 | 2024 | 124 | 0.240 |
Why?
|
| Inflammation | 4 | 2025 | 1146 | 0.240 |
Why?
|
| Body Patterning | 2 | 2016 | 82 | 0.240 |
Why?
|
| Remyelination | 1 | 2025 | 3 | 0.240 |
Why?
|
| Neural Inhibition | 1 | 2025 | 30 | 0.230 |
Why?
|
| Cell Death | 3 | 2025 | 284 | 0.230 |
Why?
|
| Skull | 2 | 2023 | 50 | 0.230 |
Why?
|
| GABAergic Neurons | 1 | 2025 | 38 | 0.230 |
Why?
|
| Mice, Transgenic | 3 | 2025 | 1276 | 0.230 |
Why?
|
| Binge Drinking | 1 | 2025 | 37 | 0.230 |
Why?
|
| Callithrix | 2 | 2025 | 21 | 0.220 |
Why?
|
| Vesicular Transport Proteins | 1 | 2025 | 113 | 0.220 |
Why?
|
| Prefrontal Cortex | 1 | 2025 | 122 | 0.220 |
Why?
|
| Optic Nerve | 1 | 2004 | 25 | 0.220 |
Why?
|
| Cell Membrane | 1 | 2006 | 493 | 0.210 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 49 | 0.210 |
Why?
|
| Brain Mapping | 1 | 2025 | 232 | 0.210 |
Why?
|
| Choroid Plexus | 1 | 2023 | 16 | 0.200 |
Why?
|
| CD47 Antigen | 1 | 2022 | 3 | 0.200 |
Why?
|
| Syk Kinase | 1 | 2022 | 9 | 0.200 |
Why?
|
| Single-Cell Analysis | 2 | 2025 | 114 | 0.200 |
Why?
|
| Hydrocephalus | 1 | 2023 | 43 | 0.190 |
Why?
|
| Interleukin-18 Receptor beta Subunit | 1 | 2022 | 2 | 0.190 |
Why?
|
| Cell Count | 2 | 2019 | 130 | 0.190 |
Why?
|
| Olfactory Bulb | 1 | 2022 | 19 | 0.190 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2022 | 16 | 0.190 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 177 | 0.190 |
Why?
|
| Polyadenylation | 1 | 2022 | 51 | 0.190 |
Why?
|
| Mitochondria | 1 | 2025 | 371 | 0.180 |
Why?
|
| Ethanol | 2 | 2025 | 322 | 0.180 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2022 | 61 | 0.180 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 70 | 0.180 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2023 | 97 | 0.180 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 40 | 0.180 |
Why?
|
| Gene Transfer Techniques | 1 | 2023 | 321 | 0.170 |
Why?
|
| Receptors, CCR2 | 1 | 2020 | 13 | 0.170 |
Why?
|
| Somatosensory Cortex | 1 | 2020 | 20 | 0.170 |
Why?
|
| Lymphocytes | 1 | 2021 | 201 | 0.170 |
Why?
|
| Capillaries | 1 | 2020 | 30 | 0.170 |
Why?
|
| Autophagy | 1 | 2023 | 225 | 0.170 |
Why?
|
| Receptors, CCR5 | 1 | 2020 | 58 | 0.170 |
Why?
|
| Receptors, Complement 3b | 1 | 2019 | 12 | 0.160 |
Why?
|
| Age Factors | 2 | 2021 | 1560 | 0.160 |
Why?
|
| Gliosis | 1 | 2019 | 28 | 0.160 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 111 | 0.160 |
Why?
|
| Oligodendrocyte Precursor Cells | 1 | 2019 | 1 | 0.160 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2019 | 25 | 0.160 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 1465 | 0.150 |
Why?
|
| Glioblastoma | 1 | 2020 | 158 | 0.150 |
Why?
|
| Complement System Proteins | 1 | 2019 | 105 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 172 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 721 | 0.140 |
Why?
|
| Cells, Cultured | 4 | 2019 | 2152 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2015 | 640 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 3 | 2009 | 424 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 619 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2020 | 985 | 0.120 |
Why?
|
| Endocytosis | 1 | 2016 | 152 | 0.120 |
Why?
|
| Nerve Net | 1 | 2016 | 97 | 0.120 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 57 | 0.120 |
Why?
|
| Antibodies | 2 | 2015 | 182 | 0.120 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 176 | 0.120 |
Why?
|
| Models, Neurological | 1 | 2015 | 80 | 0.120 |
Why?
|
| Myeloid Cells | 1 | 2015 | 94 | 0.110 |
Why?
|
| Craniotomy | 1 | 2014 | 20 | 0.110 |
Why?
|
| Pregnancy | 1 | 2021 | 2330 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2022 | 1514 | 0.110 |
Why?
|
| Cell Differentiation | 2 | 2019 | 1348 | 0.110 |
Why?
|
| Stroke | 1 | 2023 | 1191 | 0.100 |
Why?
|
| Cell Survival | 1 | 2015 | 569 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2015 | 230 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2019 | 1539 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1617 | 0.100 |
Why?
|
| Gangliosides | 1 | 2011 | 18 | 0.090 |
Why?
|
| Polyneuropathies | 1 | 2011 | 11 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 264 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2009 | 608 | 0.090 |
Why?
|
| Spectrin | 2 | 2011 | 8 | 0.090 |
Why?
|
| Calpain | 1 | 2009 | 7 | 0.080 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2009 | 21 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5448 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 92 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2009 | 75 | 0.080 |
Why?
|
| Brain Infarction | 1 | 2009 | 21 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 156 | 0.080 |
Why?
|
| Hypoxia | 1 | 2009 | 115 | 0.070 |
Why?
|
| Middle Aged | 3 | 2021 | 17549 | 0.070 |
Why?
|
| Brain Chemistry | 2 | 2009 | 76 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 364 | 0.070 |
Why?
|
| Transfection | 1 | 2009 | 692 | 0.070 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2006 | 13 | 0.060 |
Why?
|
| Glucose | 1 | 2009 | 467 | 0.060 |
Why?
|
| Ankyrins | 1 | 2006 | 3 | 0.060 |
Why?
|
| Gap Junctions | 1 | 2006 | 17 | 0.060 |
Why?
|
| Chemokine CCL11 | 1 | 2025 | 2 | 0.060 |
Why?
|
| Optogenetics | 1 | 2025 | 32 | 0.060 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2025 | 15 | 0.060 |
Why?
|
| Demyelinating Diseases | 1 | 2025 | 16 | 0.060 |
Why?
|
| Models, Biological | 1 | 2010 | 1177 | 0.060 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 87 | 0.060 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2004 | 14 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 68 | 0.050 |
Why?
|
| Detergents | 1 | 2004 | 34 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 2164 | 0.050 |
Why?
|
| Atrophy | 1 | 2024 | 83 | 0.050 |
Why?
|
| Profilins | 1 | 2024 | 45 | 0.050 |
Why?
|
| Solubility | 1 | 2004 | 179 | 0.050 |
Why?
|
| Aged | 1 | 2019 | 14390 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2004 | 197 | 0.050 |
Why?
|
| Intravital Microscopy | 1 | 2023 | 12 | 0.050 |
Why?
|
| Models, Animal | 1 | 2024 | 236 | 0.050 |
Why?
|
| Beclin-1 | 1 | 2023 | 22 | 0.050 |
Why?
|
| Proteomics | 1 | 2025 | 284 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2023 | 54 | 0.050 |
Why?
|
| Head | 1 | 2023 | 55 | 0.050 |
Why?
|
| Protein Transport | 1 | 2004 | 401 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2022 | 138 | 0.050 |
Why?
|
| Sirolimus | 1 | 2023 | 92 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2023 | 85 | 0.050 |
Why?
|
| Odorants | 1 | 2022 | 17 | 0.050 |
Why?
|
| Smell | 1 | 2022 | 28 | 0.050 |
Why?
|
| Complement C1q | 1 | 2021 | 8 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 94 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 771 | 0.040 |
Why?
|
| Oxygen | 1 | 2023 | 315 | 0.040 |
Why?
|
| Sulfoxides | 1 | 2020 | 16 | 0.040 |
Why?
|
| CCR5 Receptor Antagonists | 1 | 2020 | 16 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2022 | 212 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 217 | 0.040 |
Why?
|
| Imidazoles | 1 | 2020 | 81 | 0.040 |
Why?
|
| White Matter | 1 | 2021 | 123 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 233 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 207 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2020 | 488 | 0.040 |
Why?
|
| RNA, Small Nuclear | 1 | 2019 | 25 | 0.040 |
Why?
|
| Autopsy | 1 | 2019 | 54 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2019 | 29 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 625 | 0.040 |
Why?
|
| Aging | 1 | 2025 | 746 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2019 | 32 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2020 | 608 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2019 | 236 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 423 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 881 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 452 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 893 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 266 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 308 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 860 | 0.030 |
Why?
|
| Mutation | 1 | 2024 | 2607 | 0.030 |
Why?
|
| Implants, Experimental | 1 | 2014 | 5 | 0.030 |
Why?
|
| Wakefulness | 1 | 2014 | 42 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2014 | 149 | 0.030 |
Why?
|
| Equipment Design | 1 | 2014 | 349 | 0.030 |
Why?
|
| Time Factors | 2 | 2011 | 3759 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2011 | 2 | 0.020 |
Why?
|
| Neural Conduction | 1 | 2011 | 31 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2011 | 30 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2011 | 26 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2011 | 69 | 0.020 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2011 | 19 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 214 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 135 | 0.020 |
Why?
|
| Rabbits | 1 | 2011 | 332 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2011 | 204 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 672 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2009 | 15 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2009 | 30 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2009 | 23 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2009 | 72 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2009 | 125 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 780 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1543 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 1184 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 16782 | 0.010 |
Why?
|